• Diana Tzankova Medical University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Sofia
  • Lily Peikova Medical University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Sofia
  • Maya Georgieva Medical University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Sofia
Keywords: pyrrole-hydrazide, hydrazone, stability, UV/VIS


A validated UV/VIS method for preliminary determination of the chemical stability and stability in close to physiological conditions of a model pyrrole hydrazide and its corresponding derivative, bearing susceptible to hydrolysis hydrazone group was developed. The evaluated substances were subjected to the influence of a variety of pH medias, representing the main physiological values of 37°C and corresponding pH values in the stomach (pH 2.0), blood (pH 7.4) and small intestine (pH 9.0). The chemical stability at strong alkali media of pH 13.0 was also evaluated. The hydrazide was found to be stable at all investigated conditions. The tested hydrazone was determined to be stable at pH of 7.4 and a temperature of 37°C and susceptible to hydrolysis at strong acidic (pH 2.0) and moderate alkali (pH 9.0) media at the same temperature. In addition, a decrease in the absorption at strong alkali media (pH 13.0) was observed, showing the compounds instability under these conditions.


Bhardwaj, V., Gumber, D,. Abbot, V., Dhimana, S. & Sharmaa, P. (2015). Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics. RSC Adv., 5, 15233.

Bijev, A. & Georgieva, M. (2010). Pyrrole-based hydra- zones synthesized and evaluated in vitro as potential tuberculostatics. Letters in Drug Design&Discovery, 7, 430-7.

Chinchilla, R., N´ajera, C. & Yus, M. (2004). Metalated Heterocycles and Their Applications in Synthetic Organic Chemistry. Chem. Rev., 104, 2667–2722.

Cox, M., Lehninger, A. L. & Nelson, D. R. (2000). Lehninger Principles of Biochemistry. New York: Worth Publishers., ISBN 1-57259-153-6.

European Pharmacopoeia 7.0.

Georgieva, M., Bijev, A., Nikolova, I. & Danchev, N. (2012). Determination of hydrolytic stability and acute toxicity of previously synthesized pyrrole-based hydrazones. Pharmacia, LIX, 1-4, 10-16.

International Council for Harmonization (ICH), Expert Working Group, 2005. Validation of Analytical Procedures: TextandMethodology Q2(R1).

Jones, R. A. (1990). Pyrroles: The synthesis and the physical and chemical aspects of the pyrrole ring, Wiley-Interscience,.

Jordanov, S., Dimitrov, G., Mancheva, I. & Stoianova, R. (1994). Organic chemistry basics, Textbook, Sofia,

Jusélius, J., & Sundholm, D. (2000). The aromatic pathways of porphins, chlorins and bacteriochlorins. Phys. Chem. Chem. Phys., 2(10), 2145–2151.

Kalia, J., & Raines, R.T. (2008). Hydrolytic Stability of Hydrazones and Oximes. Angew Chem Int Ed Engl., 47(39), 7523–7526

Katritzky, A. R., Barczynski, P., Musumarra, G., Pisano, D. & Szafran, M. (1989). Aromaticity as a quantitative concept. 1. A statistical demonstration of the orthogonality of classical and magnetic aromaticity in five- and six-membered heterocycles. J. Am. Chem. Soc., 111, 7–15.

Kong, F. & Singh, R.P. (2008). Disintegration of solid foods in human stomach, J. Food Sci., 73(5), 67–80.

Kovaříková, P., Mokrý, M., Klimeš, J. & Vávrová K. (2006) HPLC study on stability of pyridoxal isonicotinoyl hydrazone. Journal of Pharmaceutical and Biomedical Analysis, 40(1), 105-112.

Lee, H., Lee, J., Lee, S., Shin, Y., Jung, W., Kim, J.-H., Park, K., Kim, K., Cho, H. S. & Ro, S. (2001). A novel class of highly potent, selective, and non-peptidic inhibitor of Ras farnesyltransferase (FTase). Bioorg. Med. Chem. Lett., 11(23), 3069–3072.

Levrand, B., Ruff, Y., Lehn, J.-M. & Herrmann, A. (2006). Controlled release of volatile aldehydes and ketones by reversible hydrazone formation – ‘‘classical’’ profragrances are getting dynamic. Chem. Commun., 2965–2967.

Loudon, M. G. (2002). Chemistry of Naphthalene and the Aromatic Heterocycles.Organic

Love, B. (1963). Method for the hydrolysis of hydrazones, US Patent.

Chemistry (4th ed.). New York: Oxford University Press, 1135–1136, ISBN 0-19-511999-1.

O’Hagan, D. (2000). Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids. Nat. Prod. Rep.,17, 435–446.

Piliego, C., Holcombe, T. W., Douglas, J. D., Woo, C. H., Beaujuge, P. M. & Fr´echet, J. M. (2010). Synthetic control of structural order in N-alkylthieno[3,4-c] pyrrole-4,6-dione-based polymers for efficient solar cells. J. Am. Chem. Soc., 132(22), 7595–7597.

Tzankova, D., Peikova, L., Vladimirova, S., Georgieva, M. (2017). Synthesis, druglikeness estimation and prediction of possible pharmacological effects of new pyrrole hydrazones. Scripta Scientifica Pharmaceutica, 4(2), 27-33.

Vladimirova, S., PhD Thesis, 2009.

Vladimirova, S., Georgieva, M. & Zlatkov, Al. (2016). Application of a gradient UHPLC method for determination of chemical and physiological stability of pyrrole-containing ester derivative. Pharm Drug Dev Ther, 1(1), 1-5.

Wilkerson, W. W., Copeland, R. A., Covington, M. & Trzaskos, J. M. (1995). Antiinflammatory 4,5-diarylpyrroles. 2. Activity as a function of cyclooxygenase-2 inhibition. J. Med. Chem., 38, 3895–3901.

Wurz, R. P. & Charette, A. B. (2005). Doubly Activated Cyclopropanes as Synthetic Precursors for the Preparation of 4-Nitro- and 4-Cyano-dihydropyrroles and Pyrroles. Org. Lett., 7(12), 2313–2316.

Zajac, M., Sobczak, A., Malinka, W. & Redzicka, A. (2010). The stability of N-[2-(4-ofluorophenylpiperazin-1-yl) ethyl]-2,5-dimethyl-1-phenylpyrrole-3,4-dicarboximide in aqueous-organic solutions. Acta Pol Pharm, 67, 27-33.